We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biomarkers Evaluated for Severity of Diabetic Kidney Disease

By LabMedica International staff writers
Posted on 24 Aug 2020
Print article
Image: iCHROMA is an automatic or semiautomatic in-vitro diagnostic device that measures via cartridges the concentration of analytes, contained in blood, urine, or other samples, in quantitative or semi-quantitative ways (Photo courtesy of Boditech Med Inc).
Image: iCHROMA is an automatic or semiautomatic in-vitro diagnostic device that measures via cartridges the concentration of analytes, contained in blood, urine, or other samples, in quantitative or semi-quantitative ways (Photo courtesy of Boditech Med Inc).
Type 2 diabetic mellitus (T2DM) is a chronic metabolic disorder with multiple complications, including diabetic retinopathy, diabetic neuropathy, diabetic kidney disease (DKD) as well as cardiovascular diseases. T2DM is related to an exacerbated systematic inflammation.

Among all plasma inflammatory biomarkers, erythrocyte sedimentation rate (ESR) and high-sensitivity C-reactive protein (hsCRP) are the mostly commonly used laboratory tests for identifying systematic inflammation. Both ESR and hsCRP are important markers in various inflammation-related diseases.

A team of endocrinologists at Huashan Hospital (Shanghai, China) conducted a cross-sectional study in 1,210 patients with T2DM, among whom 265 had DKD. The severity of DKD was assessed by estimated-glomerular filtration rate (eGFR) and urinary albumin creatinine ratio (ACR). The relationship between ESR, hsCRP and DKD was analyzed by multivariate logistic analysis. The relationship between ESR and eGFR, ESR or ACR was analyzed by multivariate linear regression.

Fasting blood sample was collected to measure fasting plasma glucose (FBG), glycated hemoglobin (HbA1c), hsCRP, serum albumin (ALB), globulin (GLB), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), serum creatinine (SCr), and ESR. ESR was measured using ESR-30 fully automatic dynamic analyzer (Xunda Medical Instrument Co., Ltd., Shanghai, China). FBG, TC, TG, HDL, LDL, ALB, total protein, SCr was quantified by Beckman AU5800 (Beckman Coulter Inc., Brea, CA, USA). HsCRP was detected by iCHROMA reader (Boditech Med Inc, Chungcheon-si, South Korea).

The scientists reported that ESR (23.0 mm/h [12.0 ~ 41.5] versus 12.0 mm/h [7.0 ~ 22.0], and hsCRP (3.60 mg/L [2.20 ~ 7.65] versus 2.90 mg/L [1.80 ~ 5.60],) values were significantly higher in patients with DKD than those without. Patients with higher ESR or hsCRP had lower eGFR and higher urinary albumin creatinine ratio (ACR). After adjusted for gender, age, hemoglobin, plasma proteins, HbA1c, lipid profiles, and the usage of renin-angiotensin system inhibitors, ESR but not hsCRP was independently associated with the rate and severity of DKD in patients with T2DM.

The authors concluded that their study underlined the role of inflammation in DKD. The study found that, both ESR and hsCRP correlated with DKD in T2DM, of which ESR was an independent risk factor for DKD and positively associated with severity of DKD. The study was published on July 13, 2020 in the journal BMC Endocrine Disorders



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more